Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of 225Ac-DOTA-rituximab using 64Cu-DOTA-rituximab.

Chul-Hee LeeIlhan LimSang-Keun WooWook KimKwang Il KimKyo Chul LeeKanghyon SongSang Moo Lim

Published in: Annals of nuclear medicine (2021)

Tumor dosimetry of 225Ac-DOTA-rituximab can be estimated via the Monte Carlo simulation of 64Cu-DOTA-rituximab. 225Ac-DOTA-rituximab can be employed for lymphoma as targeted alpha therapy.

Keyphrases

diffuse large b cell lymphoma
pet ct
pet imaging
monte carlo
chronic lymphocytic leukemia
hodgkin lymphoma
cancer therapy
positron emission tomography
stem cells
computed tomography
drug delivery
mesenchymal stem cells
cell therapy